Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Recruiting · NCT07069699 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-10-06 | NCT07069699 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UC Irvine Health/Chao Family Comprehensive Cancer Center | Orange | United States | 189 |
| UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care | Irvine | United States | 95 |
| University of Kansas Cancer Center | Kansas City | United States | 242 |
| University of Kansas Clinical Research Center | Fairway | United States | 81 |
| University of Kansas Hospital-Indian Creek Campus | Overland Park | United States | 89 |
| University of Kansas Hospital-Westwood Cancer Center | Westwood | United States | 205 |
| University of Oklahoma Health Sciences Center | Oklahoma City | United States | 491 |
| UPMC Hillman Cancer Center | Pittsburgh | United States | 330 |